ctrl K

Price Alert

Zentalis Pharmaceuticals ... (ZNTL)

NASDAQ: ZNTL · Real-Time Price · USD

1.61

0.13 (8.78%)

At close: Aug 15, 2025, 3:08 PM

Zentalis Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	33.9M	28.04M	43.07M	59.71M
Short-Term Investments	337.18M	454.88M	394.3M	280.17M
Long-Term Investments	n/a	2.68M	21.21M	37.49M
Other Long-Term Assets	7.04M	6.82M	-1.8M	2.63M
Receivables	5M	n/a	7.04M	2.63M
Inventory	n/a	n/a	-7.04M	-4.44M
Other Current Assets	n/a	n/a	n/a	2.05M
Total Current Assets	386.07M	496.72M	451.93M	350.77M
Property-Plant & Equipment	37.23M	41.73M	50.08M	52.84M
Goodwill & Intangibles	n/a	3.74M	3.74M	3.74M
Total Long-Term Assets	44.27M	54.97M	87.38M	103.74M
Total Assets	430.34M	551.69M	539.31M	454.51M
Account Payables	7.44M	14.93M	11.25M	11.59M
Deferred Revenue	n/a	n/a	-2.16M	n/a
Short-Term Debt	3.07M	2.62M	2.16M	1.45M
Other Current Liabilities	n/a	-2.62M	384K	20.2M
Total Current Liabilities	52.73M	69.37M	56.65M	43.94M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	849K	1.78M	2.62M	n/a
Total Long-Term Liabilities	40.43M	44.93M	48.64M	46.08M
Total Liabilities	93.15M	114.3M	105.29M	90.03M
Total Debt	39.58M	43.15M	47.33M	45.91M
Common Stock	71K	70K	59K	45K
Retained Earnings	-1.05B	-888.56M	-596.37M	-359.56M
Comprehensive Income	558K	2.19M	-1.35M	-125K
Shareholders Equity	337.19M	437.28M	434.02M	364.48M
Total Investments	337.18M	454.88M	415.51M	317.67M